VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration

• Status: Unknown status
• Trial end date: 2018-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is a prospective cohort study aiming to evaluate an improved VPIA remifentanil algorithm which would benefit labouring mothers who are unable or unwilling to receive epidural analgesia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: KK Women's and Children's Hospital
• Treatments: Analgesics; Remifentanil

Criteria

Inclusion Criteria:

• Patients who choose to use parenteral opioid for pain relief with informed consent

• Patients who refuse labour epidural analgesia or with contraindication to epidural analgesia (eg. thrombocytopaenia, previous thoraco-lumbar spinal instrumentation)

• Gestational age of >= 36 weeks

Exclusion Criteria:

• Patients who are unable to understand instructions given regarding the use of patient controlled analgesia (PCA) or unable to self administer PCA boluses

• Patients with difficulty in communication due to language differences

• Patients with known hypersensitivity to remifentanil or any component of its formulation or to other fentanyl analogue

• Patients with severe respiratory disease

• Patients with history of drug dependence of recreational drug abuse

• Patients with unmanaged foetal bradycardia